Trials / Completed
CompletedNCT02585648
Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dry eye syndrome is a highly prevalent ocular disease with an increasing incidence in the elderly population. Topically administered lubricants are the basis for treatment of this disease. Relief of symptoms in patients with moderate to severe dry eye disease is usually reached by the use of artificial tears during the day. Nighttime relief is often achieved by substances known to be more adhesive to the ocular surface, such as gels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thealoz Duo Gel and Thealoz Duo eye drops | Thealoz Duo gel at night (1 drop before going to bed) + Thealoz Duo eye drops during the day (4 to 6 drops per day) |
| DEVICE | Thealoz Duo eye drops | Thealoz Duo eye drops during the day (4 to 6 drops per day) |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-05-01
- Completion
- 2016-11-01
- First posted
- 2015-10-23
- Last updated
- 2017-03-27
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02585648. Inclusion in this directory is not an endorsement.